The Correlation Between the Subsets of Tumor Infiltrating Memory T Cells and the Expression of Indoleamine 2,3-Dioxygenase in Gastric Cancer

被引：0
|
作者：
Rupeng Zhang
Hui Liu
Fangxuan Li
Hui Li
Jinpu Yu
Xiubao Ren
机构：
[1] Key Laboratory of Cancer Prevention and Therapy,Department of Gastric Cancer Surgery, Tianjin Medical University Cancer Institute and Hospital
[2] Key Laboratory of Cancer Prevention and Therapy,Cancer Prevention Center, Tianjin Medical University Cancer Institute and Hospital
[3] Key Laboratory of Cancer Prevention and Therapy,Department of Immunology, Tianjin Medical University Cancer Institute and Hospital
来源：
Digestive Diseases and Sciences | 2013年 / 58卷
关键词：
Tumor-infiltrating T cells; Indoleamine 2,3-dioxygenase; Memory T cells; Gastric cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3494 / 3502
页数：8
相关论文
共 50 条
  • [31] Indoleamine 2,3-dioxygenase in immune suppression and cancer
    Muller, Alexander J.
    Prendergast, George C.
    CURRENT CANCER DRUG TARGETS, 2007, 7 (01) : 31 - 40
  • [32] Indoleamine 2,3-dioxygenase, the immune response and cancer
    Groves, John
    Nelp, Micah
    Kates, Patrick
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 255
  • [33] Targeting the indoleamine 2,3-dioxygenase pathway in cancer
    Moon, Yong Wha
    Hajjar, Joud
    Hwu, Patrick
    Naing, Aung
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2015, 3
  • [34] (-)-Epigallocatechin gallate inhibits the expression of indoleamine 2,3-dioxygenase in human colorectal cancer cells
    Ogawa, Kengo
    Hara, Takeshi
    Shimizu, Masahito
    Nagano, Junji
    Ohno, Tomohiko
    Hoshi, Masato
    Ito, Hiroyasu
    Tsurumi, Hisashi
    Saito, Kuniaki
    Seishima, Mitsuru
    Moriwaki, Hisataka
    ONCOLOGY LETTERS, 2012, 4 (03) : 546 - 550
  • [35] Expression of indoleamine 2,3-dioxygenase in acute leukemic cells and the clinical significance
    Chen, Xiang-Li
    Guo, Jian-Min
    Zhang, Yin
    Niu, Xiao-Na
    Pei, Xiao-Hang
    Zhang, Wen-Hui
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (05): : 8605 - 8609
  • [36] Clinicopathological significance of indoleamine 2,3-dioxygenase 1 expression in colorectal cancer
    Ferdinande, L.
    Decaestecker, C.
    Verset, L.
    Mathieu, A.
    Lopez, X. Moles
    Negulescu, A-M
    Van Maerken, T.
    Salmon, I.
    Cuvelier, C. A.
    Demetter, P.
    BRITISH JOURNAL OF CANCER, 2012, 106 (01) : 141 - 147
  • [37] Decreased indoleamine 2,3-dioxygenase expression in dendritic cells and role of indoleamine 2,3-dioxygenase-expressing dendritic cells in immune thrombocytopenia
    Xu, Shu-qian
    Wang, Chun-yan
    Zhu, Xiao-juan
    Dong, Xiao-yuan
    Shi, Yan
    Peng, Jun
    Qin, Ping
    Sun, Jian-zhi
    Guo, Chengshan
    Ni, Heyu
    Hou, Ming
    ANNALS OF HEMATOLOGY, 2012, 91 (10) : 1623 - 1631
  • [38] Decreased indoleamine 2,3-dioxygenase expression in dendritic cells and role of indoleamine 2,3-dioxygenase-expressing dendritic cells in immune thrombocytopenia
    Shu-qian Xu
    Chun-yan Wang
    Xiao-juan Zhu
    Xiao-yuan Dong
    Yan Shi
    Jun Peng
    Ping Qin
    Jian-zhi Sun
    Chengshan Guo
    Heyu Ni
    Ming Hou
    Annals of Hematology, 2012, 91 : 1623 - 1631
  • [39] Cells expressing indoleamine 2,3-dioxygenase inhibit T cell responses
    Mellor, AL
    Keskin, DB
    Johnson, T
    Chandler, P
    Munn, DH
    JOURNAL OF IMMUNOLOGY, 2002, 168 (08): : 3771 - 3776
  • [40] Indoleamine 2,3-dioxygenase and tumor-induced tolerance
    Munn, David H.
    Mellor, Andrew L.
    JOURNAL OF CLINICAL INVESTIGATION, 2007, 117 (05): : 1147 - 1154
12345